CMC Service
Home - Services & Solutions - CMC Service
CMC Service

CMC Service

We provide our customers with fully compliant one-stop solution from pre-clinical to final commercial manufacturing, including synthetical route scouting & optimization, impurity characterization and control strategy, specification and analytical method development, stability study, global submission, and commercial supply.

Our Services

Our Services

Synthetic route scouting and optimization

Impurity characterization and control strategy

Quality control strategy

Method development and validation

Critical process parameter identification and process validation

Stability studies

Global regulatory submission

Pre-clinical and commercial material supply

Transportation validation

Our Services

Synthetic Route Scouting and Optimization

Synthetic route scouting in lab

Pilot synthetic process optimization

Full scale synthetic process optimization

Identification of regulatory start material

Impurity Characterization and Control Strategy

Impurity profile studies: organic impurities, inorganic impurities, elemental impurities, residual solvents, degradation impurities, potential genotoxic impurities

Genotoxic impurity studies: Prediction of genotoxicity of impurities based on Derek/Sarah software, and Limit determination for genotoxic impurities based on ICH M7 guidelines

Impurity characterization: Impurity preparation, separation, and structure elucidation by pre-HPLC, LC-MS, GC-MS, FT-IR, NMR, etc.

Impurity control strategy: understand the fate of impurities, including source, purge and control strategy, and determine the impurity profile and limits based on safety risk assessment

Method Development and Validation

Chirality method

Particle size distribution (PSD)

Ion content and residues

Elemental impurities

Low content genotoxic impurities (GTI)

Residual solvents

Polymorph determination

Related substances/assay

Critical process parameter identification and process validation

Identification and control of CQA

Identification of CPP and control strategy based on QRA

Full scale process validation

Stability Study

Forced degradation and stress tests (Light, acid, alkali, oxidation, high temperature, and high humidity)

Accelerated and long term stability program as per ICH Q1 and NMPA guidelines (40°C /75%RH, 30°C /65%RH, 25°C /60%RH, 5°C)

Follow-up stability program in the commercialization phase

Global Regulatory Submission

Establishment of impurity control strategy

Specification development and justification

CMC document drafting

Trouble shooting of potential CMC deficiencies.

IND/NDA filing

Pre-clinical and commercial validation

Full GMP compliant product manufacturing

Excellent data integrity management system

Proved tracking record on Health Authority inspection and customer audits

Strong integration capability to ensure stable and on-time delivery

Comprehensive ESG management system

What Can We Help You?

We provide customers with one-stop CRDMO services covering the entire lifecycle of drugs.

Introduction

We use cookies on our website to better understand how you use our website. For more information about how we use cookies, please visit our Terms of Use and Legal Notices and Privacy Statement and Cookies Policy. By continuing to use this website without changing your settings, you will be deemed to have consented to our use of cookies.